For instance, papers focusing on ARS may describe patients with a terminal 6p/FOXC1 deletion who were identified because they had the ocular phenotype, resulting in an overestimation of this phenotype. This evidence concerns the gene FOXC1 and Axenfeld-Rieger syndrome.